{"result": {"id": "chatcmpl-515", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Sunitinib** is a tyrosine kinase inhibitor used in both research and clinical settings. It targets specific cancer cells by inhibiting their growth, primarily through blocking the activity of genes involved in cell growth, particularly those with mutations (CNV) associated with various types of cancers.  Sunitinib's effectiveness stems from its ability to block angiogenesis, the formation of new blood vessels, which is crucial for tumor growth and spread. However, Sunitinib faces challenges due to low bioavailability and short half-life, necessitating a suitable drug delivery system for optimal therapeutic efficacy. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743241094, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 118, "prompt_tokens": 247, "total_tokens": 365, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"SUNITINIB\"\nDescription List: [\"Sunitinib is a drug used in both research and clinical settings. It is a tyrosine kinase inhibitor that targets specific cancer cells by inhibiting their growth.  Sunitinib's effectiveness stems from its ability to block the activity of certain genes involved in cell growth, particularly those with mutations (CNV) associated with various types of cancers. \\n\", \"Sunitinib needs a suitable drug delivery system to overcome low bioavailability and short half-life\\nSunitinib is a small hydrophobic molecule used to inhibit angiogenesis\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_7b4ffbf907de6f0841c60521f36dc0067a88e17986cf7dbc0b2c48b67f805cbb_v2"}